CFPs: Applied Biotechnology and Phytotherapy Research to Strengthen the Pharmaceutical Sector (Senegal)

Deadline: 02-Mar-2026

Enabel Senegal invites proposals to support applied research initiatives in biotechnologies and phytotherapy, aiming to strengthen the local pharmaceutical industry. Funding targets projects that generate concrete scientific outputs, build national research capacity, and contribute to sustainable local medicine production, with grants of EUR 20,000–22,000 per project.

Overview of the Initiative

This Enabel call for proposals supports Senegalese initiatives that contribute to the sustainable strengthening of the local pharmaceutical industry. The program focuses on applied research in biotechnology and phytotherapy to valorize local medicinal resources, enhance national scientific capacities, and support the development of safe and effective local medicines.

Key Focus Areas

Applied Research in Biotechnologies and Phytotherapy

• Conception and development of innovative medicinal products

• Valorization of local medicinal resources and biodiversity

• Experimental prototypes, proof of concept, and locally validated pilot batches

• Strengthening technical and organizational capacities of public research teams

Sustainable Pharmaceutical Industry Development

• Support Senegal’s pharmaceutical sector recovery plan

• Promote local production of medicines and health products

• Contribute to national pharmaceutical sovereignty and supply chain resilience

Scientific and Technological Outputs

• Achieve verifiable scientific results

• Demonstrate progress in scientific and technological maturity

• Enable small-scale experimental production where applicable

Funding and Eligibility

• Indicative Budget: EUR 110,000 for the call

• Number of Projects: Up to five selected projects

• Grant per Project: EUR 20,000–22,000

• Implementation Period: 15–18 months

• Eligible Actions: Applied research and experimental development activities in Senegal

• Projects must align with call objectives and contribute to innovative, effective, safe, and non-toxic biotechnological or phyto-biotechnological products

Objectives and Expected Outcomes

• Strengthen applied research capacity in Senegal’s pharmaceutical sector

• Produce concrete scientific and technological outputs (proofs of concept, experimental prototypes, pilot batches)

• Support sustainable valorization of local medicinal resources

• Enhance national pharmaceutical sovereignty and resilience

• Build technical and organizational capabilities of public research teams

How to Apply

1. Confirm eligibility as a research team or institution based in Senegal.

2. Develop a detailed project proposal addressing applied research and experimental development in biotechnology or phytotherapy.

3. Include objectives, methodology, expected outputs, timelines, and budget within EUR 20,000–22,000.

4. Submit the proposal through Enabel’s official call for proposals portal.

5. Ensure alignment with Senegal’s pharmaceutical sector recovery plan and national objectives for local medicine production.

Common Mistakes to Avoid

• Proposing projects outside the scope of applied biotechnology or phytotherapy research

• Failing to demonstrate concrete scientific or technological outputs

• Omitting capacity-building or organizational development components

• Not aligning the project with national pharmaceutical recovery objectives

• Providing incomplete timelines, budgets, or methodological details

FAQs

1. Who can apply? Public research teams and institutions based in Senegal.

2. What is the maximum grant per project? EUR 22,000.

3. How many projects will be funded? Up to five projects.

4. What is the expected implementation period? 15–18 months.

5. What types of activities are eligible? Applied research and experimental development in biotechnologies and phytotherapy.

6. What outputs are expected? Proof of concept, experimental prototypes, and pilot batches validated locally.

7. How does this contribute to Senegal’s pharmaceutical industry? By strengthening local production, research capacity, and sustainable valorization of medicinal resources.

Conclusion

Enabel’s Senegal pharmaceutical research grant provides vital support for applied biotechnology and phytotherapy projects that strengthen national research capacities, promote local medicine production, and advance sustainable pharmaceutical development. By funding initiatives with concrete scientific outputs and organizational capacity-building, the program contributes to long-term pharmaceutical sovereignty and resilient health systems in Senegal.

For more information, visit Enabel.